
Analysis depression: Difference between revisions
>Josikins revisiting effect overhauls and proofreading/adding minor tweaks |
>Josikins grammatical overhaul |
||
Line 1: | Line 1: | ||
<onlyinclude>'''Analysis suppression''' can be described as a distinct decrease in | <onlyinclude>'''Analysis suppression''' can be described as a distinct decrease in a person's overall ability to process information and logically or creatively analyze concepts, ideas, and scenarios. The experience of this effect leads to significant difficulty contemplating or understanding basic ideas in a manner which can temporarily prevent normal cognitive functioning. | ||
Analysis suppression is often accompanied by other coinciding effects such as [[sedation]], [[thought deceleration]], and [[emotion suppression]]. It is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[antipsychotic]] compounds, such as [[quetiapine]], [[haloperidol]], and [[risperidone]]. However, it can also occur in a less consistent form under the influence of [[dosage#heavy|heavy]] dosages of [[dissociative|dissociatives]], [[cannabinoid|cannabinoids]], and [[GABAergic|GABAergic]] [[depressant|depressants]]. | Analysis suppression is often accompanied by other coinciding effects such as [[sedation]], [[thought deceleration]], and [[emotion suppression]]. It is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[antipsychotic]] compounds, such as [[quetiapine]], [[haloperidol]], and [[risperidone]]. However, it can also occur in a less consistent form under the influence of [[dosage#heavy|heavy]] dosages of [[dissociative|dissociatives]], [[cannabinoid|cannabinoids]], and [[GABAergic|GABAergic]] [[depressant|depressants]]. |
Revision as of 23:50, 10 April 2018
Analysis suppression can be described as a distinct decrease in a person's overall ability to process information and logically or creatively analyze concepts, ideas, and scenarios. The experience of this effect leads to significant difficulty contemplating or understanding basic ideas in a manner which can temporarily prevent normal cognitive functioning.
Analysis suppression is often accompanied by other coinciding effects such as sedation, thought deceleration, and emotion suppression. It is most commonly induced under the influence of moderate dosages of antipsychotic compounds, such as quetiapine, haloperidol, and risperidone. However, it can also occur in a less consistent form under the influence of heavy dosages of dissociatives, cannabinoids, and GABAergic depressants.
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 1,4-Butanediol
- 2M2B
- 3-MeO-PCE
- 3-MeO-PCMo
- 4-MeO-PCP
- 5F-AKB48
- 5F-PB-22
- AB-FUBINACA
- APICA
- Alcohol
- Alprazolam
- Amanita muscaria
- Baclofen
- Barbiturates
- Benzodiazepines
- Bromazepam
- Cannabis
- Carisoprodol
- Clonazepam
- Clonazolam
- DOB
- Deschloroetizolam
- Deschloroketamine
- Dextromethorphan
- Diazepam
- Diclazepam
- Diphenhydramine
- Diphenidine
- Ephenidine
- Eszopiclone
- Etizolam
- F-Phenibut
- Flualprazolam
- Flubromazepam
- Flubromazolam
- Flunitrazepam
- Flunitrazolam
- GBL
- GHB
- Gabapentin
- Gaboxadol
- HXE
- JWH-018
- JWH-073
- Ketamine
- Lorazepam
- Memantine
- Methaqualone
- Methoxetamine
- Methoxphenidine
See also
- Responsible use
- Subjective effects index
- Psychedelics - Subjective effects
- Dissociatives - Subjective effects
- Deliriants - Subjective effects